Skip to main content

Table 1 CMR parameters and clinical characteristics of patients at high- and low-risk for sudden cardiac death

From: Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy

 

Patients at

High risk

Patients at

Low-risk

p-values

n

43

33

 

male gender

28

20

0.50

Age

57 ± 14

61 ± 10

0.29

CMR parameters

   

EF (%)

57 ± 4

62 ± 10

0.09

EDM (g)

195 ± 58

181 ± 76

0.36

EDV (ml)

156 ± 53

139 ± 42

0.14

ESV (ml)

67 ± 32

54 ± 28

0.07

SV (ml)

88 ± 30

84 ± 28

0.58

LVEDD (mm)

50 ± 7

49 ± 7

0.54

SWT (mm)

20 ± 5

17 ± 4

0.004

PWT (mm)

10 ± 3

10 ± 2

0.91

RVEDD (mm)

43 ± 6

42 ± 7

0.42

RVESD (mm)

28 ± 6

28 ± 7

0.76

Presence

of LGE

29/43

(67%)

14/33

(47%)

0.03

% of LV mass with LGE

14%

3%

0.001

Clinical characteristics

   

Dyspnea

11

4

0.14

Chest pain

13

5

0.12

Atrial fibrillation

18

3

0.26

HCM with obstruction

25

10

0.06

Diabetes

4

5

0.35

Hypertension

25

19

0.49

Hyperlipidemia

10

13

0.13

  1. EDM = enddiastolic mass; EDV = enddiastolic volume; EF = ejection fraction; ESV = endsystolic volume; LGE = Late gadolinium enhancement; LV = left ventricular; Presence of LGE = Number of patients in whom LGE was detectable; LVEDD = left ventricular enddiastolic diameter; PWT = posterior-wall-thickness; RVEDD/RVESD = right ventricular enddiastolic/enddiastolic diameter; SV = stroke volume; SWT = Septal-wall-thickness; (Mean value ± standard deviation).